BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9516865)

  • 1. Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
    Cheung NK; Kushner BH; LaQuaglia MP; Kramer K; Ambros P; Ambros I; Ladanyi M; Eddy J; Bonilla MA; Gerald W
    Eur J Cancer; 1997 Oct; 33(12):2117-20. PubMed ID: 9516865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
    Ambros PF; Ambros IM; Strehl S; Bauer S; Luegmayr A; Kovar H; Ladenstein R; Fink FM; Horcher E; Printz G
    Eur J Cancer; 1995; 31A(4):510-5. PubMed ID: 7576955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
    Mora J; Cheung NK; Chen L; Qin J; Gerald W
    Cancer; 2001 Jan; 91(2):435-42. PubMed ID: 11180092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
    Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Gerald WL; Ladanyi M; Gilbert F; Rosenfield NS; Yeh SD
    J Clin Oncol; 1996 Feb; 14(2):373-81. PubMed ID: 8636746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma.
    Kramer K; Cheung NK; Gerald WL; LaQuaglia M; Kushner BH; LeClerc JM; LeSauter L; Saragovi HU
    Eur J Cancer; 1997 Oct; 33(12):2098-100. PubMed ID: 9516861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with International Neuroblastoma Staging System and Pathology Classification.
    Ikeda H; Iehara T; Tsuchida Y; Kaneko M; Hata J; Naito H; Iwafuchi M; Ohnuma N; Mugishima H; Toyoda Y; Hamazaki M; Mimaya J; Kondo S; Kawa K; Okada A; Hiyama E; Suita S; Takamatsu H
    Br J Cancer; 2002 Apr; 86(7):1110-6. PubMed ID: 11953858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
    van Wezel EM; Decarolis B; Stutterheim J; Zappeij-Kannegieter L; Berthold F; Schumacher-Kuckelkorn R; Simon T; Fiocco M; van Noesel MM; Caron HN; van der Schoot CE; Hero B; Tytgat GAM
    Eur J Cancer; 2016 Feb; 54():149-158. PubMed ID: 26796600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of risk.
    Kushner BH; LaQuaglia MP; Kramer K; Cheung NK
    J Pediatr Hematol Oncol; 2004 Jan; 26(1):35-9. PubMed ID: 14707711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
    Paulino AC; Mayr NA; Simon JH; Buatti JM
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
    Svensson T; Rydén M; Schilling FH; Dominici C; Sehgal R; Ibáñez CF; Kogner P
    Eur J Cancer; 1997 Oct; 33(12):2058-63. PubMed ID: 9580079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma.
    Mora J; Gerald WL; Qin J; Cheung NK
    Cancer; 2002 May; 94(10):2756-65. PubMed ID: 12173347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcome of stage 3 neuroblastoma.
    Modak S; Kushner BH; LaQuaglia MP; Kramer K; Cheung NK
    Eur J Cancer; 2009 Jan; 45(1):90-8. PubMed ID: 18996003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
    Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
    Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
    Schmidt ML; Lukens JN; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Perez C; Haase GM; Matthay KK
    J Clin Oncol; 2000 Mar; 18(6):1260-8. PubMed ID: 10715296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term follow-up of neuroblastoma in children less than 18 months of age].
    Zhao J; Pan C; Xu M; Zhou M; Gao YJ; Hu WT; Tang JY
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):754-759. PubMed ID: 29050113
    [No Abstract]   [Full Text] [Related]  

  • 17. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
    Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
    J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.
    Kushner BH; Kramer K; LaQuaglia MP; Modak S; Cheung NK
    Pediatr Blood Cancer; 2006 Mar; 46(3):278-84. PubMed ID: 16124002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
    Rubie H; Delattre O; Hartmann O; Combaret V; Michon J; Bénard J; Peyroulet MC; Plantaz D; Coze C; Chastagner P; Baranzelli MC; Frappaz D; Lemerle J; Sommelet D
    Eur J Cancer; 1997 Oct; 33(12):1917-22. PubMed ID: 9516824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current contribution of molecular factors to risk estimation in neuroblastoma patients.
    Berthold F; Sahin K; Hero B; Christiansen H; Gehring M; Harms D; Horz S; Lampert F; Schwab M; Terpe J
    Eur J Cancer; 1997 Oct; 33(12):2092-7. PubMed ID: 9516860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.